Skip to main content

Table 3 Standard curve performance of reduced hIL-33 iPCR

From: Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

Nominal conc (pg/mL) Measured mean conc (pg/mL) % Recovery %CV
20 19.06 95.3 1.5
10 9.93 99.3 1.2
5 5.18 103.6 1.2
2.5 2.32 92.9 1.3
1.25 1.24 98.9 1.5
0.63 0.63 101.0 0.9
0.31 0.31 98.2 1.2
0.16 0.15 97.3 0.9
0.078 0.074 94.8 1.1
  1. n = 6 independent assay runs. LLOQ = 0.078 pg/mL, ULOQ = 20 pg/mL